Increased resistance to acetaminophen-induced hepatotoxicity in retrovirus-infected mice

Hsiao-Hui Chow, Yang Tang, Ping Li, Robin L. Fisher, Klaus Brendel, Ronald R Watson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In this research we examined the influence of chronic retrovirus infection on the hepatic metabolism of a model substrate, acetaminophen (APAP), and its induced liver injury in mice inoculated with LP-BM5 murine leukemia viruses. Female C57BL/6 mice at 15-17 wks after LP-BM5 retrovirus inoculation and age-matched control animals were used in the studies. APAP treatment (300 mg kg-1, p.o.) resulted in moderate to severe centrilobular necrosis in control animals, with the necrotic area accounting for 40-60% of the total area. In contrast, the APAP-treated (300 mg kg-1, p.o.) infected animals exhibited mild zonal necrosis with the necrotic area accounting for 1-6% of the total area. In the same study, a statistically significant higher percentage of APAP glucuronide and a lower percentage of unchanged APAP were recovered from the urine of the LP-BM5-inoculated animals than from that of controls. No statistically significant differences between infected and uninfected animals in the urinary recovery of APAP sulfate, APAP cysteine, or APAP mercapturate were observed. The formation of APAP metabolites and APAP-associated biochemical changes were also determined from liver slice preparation to avoid in vivo complicating factors. Consistently more significant depletion of the intracellular glutathione levels and K+ content were observed in slices from the uninfected animals at high concentrations of APAP (1 and 2 mM) than in slices from the retrovirus-infected animals. The differences in APAP-associated biochemical changes were accompanied by a 1.4-1.5-fold increase in the formation of APAP glucuronide, sulfate, and glutathione metabolites in slices prepared from animals inoculated with LP-BM5. We concluded that, based on histological examination and hepatic biochemical measurements, the retrovirus-infected animals were more resistant to APAP-induced liver injury. This could be due, in part, to alterations in the detoxification and activation metabolic pathways of APAP.

Original languageEnglish (US)
Pages (from-to)661-674
Number of pages14
JournalBiopharmaceutics and Drug Disposition
Volume17
Issue number8
DOIs
StatePublished - Nov 1996

Fingerprint

Retroviridae
Acetaminophen
Liver
Glucuronides
Sulfates
Glutathione
Necrosis
Retroviridae Infections
Murine Leukemia Viruses
Wounds and Injuries
Metabolic Networks and Pathways
Inbred C57BL Mouse
Cysteine

Keywords

  • APAP
  • chronic retrovirus infection
  • hepatic metabolism
  • hepatotoxicity
  • mice

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Increased resistance to acetaminophen-induced hepatotoxicity in retrovirus-infected mice. / Chow, Hsiao-Hui; Tang, Yang; Li, Ping; Fisher, Robin L.; Brendel, Klaus; Watson, Ronald R.

In: Biopharmaceutics and Drug Disposition, Vol. 17, No. 8, 11.1996, p. 661-674.

Research output: Contribution to journalArticle

Chow, Hsiao-Hui ; Tang, Yang ; Li, Ping ; Fisher, Robin L. ; Brendel, Klaus ; Watson, Ronald R. / Increased resistance to acetaminophen-induced hepatotoxicity in retrovirus-infected mice. In: Biopharmaceutics and Drug Disposition. 1996 ; Vol. 17, No. 8. pp. 661-674.
@article{8aff6ad5294c497ca32e3aaa6f4b90f7,
title = "Increased resistance to acetaminophen-induced hepatotoxicity in retrovirus-infected mice",
abstract = "In this research we examined the influence of chronic retrovirus infection on the hepatic metabolism of a model substrate, acetaminophen (APAP), and its induced liver injury in mice inoculated with LP-BM5 murine leukemia viruses. Female C57BL/6 mice at 15-17 wks after LP-BM5 retrovirus inoculation and age-matched control animals were used in the studies. APAP treatment (300 mg kg-1, p.o.) resulted in moderate to severe centrilobular necrosis in control animals, with the necrotic area accounting for 40-60{\%} of the total area. In contrast, the APAP-treated (300 mg kg-1, p.o.) infected animals exhibited mild zonal necrosis with the necrotic area accounting for 1-6{\%} of the total area. In the same study, a statistically significant higher percentage of APAP glucuronide and a lower percentage of unchanged APAP were recovered from the urine of the LP-BM5-inoculated animals than from that of controls. No statistically significant differences between infected and uninfected animals in the urinary recovery of APAP sulfate, APAP cysteine, or APAP mercapturate were observed. The formation of APAP metabolites and APAP-associated biochemical changes were also determined from liver slice preparation to avoid in vivo complicating factors. Consistently more significant depletion of the intracellular glutathione levels and K+ content were observed in slices from the uninfected animals at high concentrations of APAP (1 and 2 mM) than in slices from the retrovirus-infected animals. The differences in APAP-associated biochemical changes were accompanied by a 1.4-1.5-fold increase in the formation of APAP glucuronide, sulfate, and glutathione metabolites in slices prepared from animals inoculated with LP-BM5. We concluded that, based on histological examination and hepatic biochemical measurements, the retrovirus-infected animals were more resistant to APAP-induced liver injury. This could be due, in part, to alterations in the detoxification and activation metabolic pathways of APAP.",
keywords = "APAP, chronic retrovirus infection, hepatic metabolism, hepatotoxicity, mice",
author = "Hsiao-Hui Chow and Yang Tang and Ping Li and Fisher, {Robin L.} and Klaus Brendel and Watson, {Ronald R}",
year = "1996",
month = "11",
doi = "10.1002/(SICI)1099-081X(199611)17:8<661::AID-BDD980>3.0.CO;2-C",
language = "English (US)",
volume = "17",
pages = "661--674",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Increased resistance to acetaminophen-induced hepatotoxicity in retrovirus-infected mice

AU - Chow, Hsiao-Hui

AU - Tang, Yang

AU - Li, Ping

AU - Fisher, Robin L.

AU - Brendel, Klaus

AU - Watson, Ronald R

PY - 1996/11

Y1 - 1996/11

N2 - In this research we examined the influence of chronic retrovirus infection on the hepatic metabolism of a model substrate, acetaminophen (APAP), and its induced liver injury in mice inoculated with LP-BM5 murine leukemia viruses. Female C57BL/6 mice at 15-17 wks after LP-BM5 retrovirus inoculation and age-matched control animals were used in the studies. APAP treatment (300 mg kg-1, p.o.) resulted in moderate to severe centrilobular necrosis in control animals, with the necrotic area accounting for 40-60% of the total area. In contrast, the APAP-treated (300 mg kg-1, p.o.) infected animals exhibited mild zonal necrosis with the necrotic area accounting for 1-6% of the total area. In the same study, a statistically significant higher percentage of APAP glucuronide and a lower percentage of unchanged APAP were recovered from the urine of the LP-BM5-inoculated animals than from that of controls. No statistically significant differences between infected and uninfected animals in the urinary recovery of APAP sulfate, APAP cysteine, or APAP mercapturate were observed. The formation of APAP metabolites and APAP-associated biochemical changes were also determined from liver slice preparation to avoid in vivo complicating factors. Consistently more significant depletion of the intracellular glutathione levels and K+ content were observed in slices from the uninfected animals at high concentrations of APAP (1 and 2 mM) than in slices from the retrovirus-infected animals. The differences in APAP-associated biochemical changes were accompanied by a 1.4-1.5-fold increase in the formation of APAP glucuronide, sulfate, and glutathione metabolites in slices prepared from animals inoculated with LP-BM5. We concluded that, based on histological examination and hepatic biochemical measurements, the retrovirus-infected animals were more resistant to APAP-induced liver injury. This could be due, in part, to alterations in the detoxification and activation metabolic pathways of APAP.

AB - In this research we examined the influence of chronic retrovirus infection on the hepatic metabolism of a model substrate, acetaminophen (APAP), and its induced liver injury in mice inoculated with LP-BM5 murine leukemia viruses. Female C57BL/6 mice at 15-17 wks after LP-BM5 retrovirus inoculation and age-matched control animals were used in the studies. APAP treatment (300 mg kg-1, p.o.) resulted in moderate to severe centrilobular necrosis in control animals, with the necrotic area accounting for 40-60% of the total area. In contrast, the APAP-treated (300 mg kg-1, p.o.) infected animals exhibited mild zonal necrosis with the necrotic area accounting for 1-6% of the total area. In the same study, a statistically significant higher percentage of APAP glucuronide and a lower percentage of unchanged APAP were recovered from the urine of the LP-BM5-inoculated animals than from that of controls. No statistically significant differences between infected and uninfected animals in the urinary recovery of APAP sulfate, APAP cysteine, or APAP mercapturate were observed. The formation of APAP metabolites and APAP-associated biochemical changes were also determined from liver slice preparation to avoid in vivo complicating factors. Consistently more significant depletion of the intracellular glutathione levels and K+ content were observed in slices from the uninfected animals at high concentrations of APAP (1 and 2 mM) than in slices from the retrovirus-infected animals. The differences in APAP-associated biochemical changes were accompanied by a 1.4-1.5-fold increase in the formation of APAP glucuronide, sulfate, and glutathione metabolites in slices prepared from animals inoculated with LP-BM5. We concluded that, based on histological examination and hepatic biochemical measurements, the retrovirus-infected animals were more resistant to APAP-induced liver injury. This could be due, in part, to alterations in the detoxification and activation metabolic pathways of APAP.

KW - APAP

KW - chronic retrovirus infection

KW - hepatic metabolism

KW - hepatotoxicity

KW - mice

UR - http://www.scopus.com/inward/record.url?scp=0029796202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029796202&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-081X(199611)17:8<661::AID-BDD980>3.0.CO;2-C

DO - 10.1002/(SICI)1099-081X(199611)17:8<661::AID-BDD980>3.0.CO;2-C

M3 - Article

C2 - 8950046

AN - SCOPUS:0029796202

VL - 17

SP - 661

EP - 674

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 8

ER -